| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.07 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |